227 related articles for article (PubMed ID: 17603740)
1. Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population.
Harley C; Li H; Corey-Lisle P; L'Italien GJ; Carson W
Soc Psychiatry Psychiatr Epidemiol; 2007 Sep; 42(9):690-7. PubMed ID: 17603740
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents.
Dusetzina SB; Weinberger M; Gaynes BN; Farley JF; Sleath B; Hansen RA
Pharmacotherapy; 2012 Dec; 32(12):1085-94. PubMed ID: 23208835
[TBL] [Abstract][Full Text] [Related]
3. Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population.
Guo JJ; Keck PE; Li H; Jang R; Kelton CM
Value Health; 2008; 11(3):416-23. PubMed ID: 18179673
[TBL] [Abstract][Full Text] [Related]
4. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
5. Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder.
Guo JJ; Keck PE; Li H; Patel NC
Psychiatr Serv; 2007 Aug; 58(8):1073-8. PubMed ID: 17664518
[TBL] [Abstract][Full Text] [Related]
6. Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a Medicaid programme.
Qiu Y; Fu AZ; Liu GG; Christensen DB
Appl Health Econ Health Policy; 2010; 8(3):167-77. PubMed ID: 20408601
[TBL] [Abstract][Full Text] [Related]
7. Service utilization and associated direct costs for bipolar disorder in 2004: an analysis in managed care.
Stensland MD; Jacobson JG; Nyhuis A
J Affect Disord; 2007 Aug; 101(1-3):187-93. PubMed ID: 17254637
[TBL] [Abstract][Full Text] [Related]
8. Mental health treatment received by youths in the year before and after a new diagnosis of bipolar disorder.
Olfson M; Crystal S; Gerhard T; Huang CS; Carlson GA
Psychiatr Serv; 2009 Aug; 60(8):1098-106. PubMed ID: 19648198
[TBL] [Abstract][Full Text] [Related]
9. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
[TBL] [Abstract][Full Text] [Related]
11. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.
Dusetzina SB; Farley JF; Weinberger M; Gaynes BN; Sleath B; Hansen RA
Psychiatr Serv; 2012 Oct; 63(10):1019-25. PubMed ID: 22855210
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
[TBL] [Abstract][Full Text] [Related]
13. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
McCombs JS; Ahn J; Tencer T; Shi L
J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.
Locklear JC; Alemayehu B; Brody RS; Chavoshi S; Tunceli O; Kern D; Earley WR
Clin Ther; 2013 Dec; 35(12):1923-32. PubMed ID: 24275622
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
[TBL] [Abstract][Full Text] [Related]
16. Trends in psychotropic medication costs for children and adolescents, 1997-2000.
Martin A; Leslie D
Arch Pediatr Adolesc Med; 2003 Oct; 157(10):997-1004. PubMed ID: 14557161
[TBL] [Abstract][Full Text] [Related]
17. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
18. Patterns of psychotropic medication use by race among veterans with bipolar disorder.
Kilbourne AM; Pincus HA
Psychiatr Serv; 2006 Jan; 57(1):123-6. PubMed ID: 16399973
[TBL] [Abstract][Full Text] [Related]
19. Health care utilization and costs among patients treated for bipolar disorder in an insured population.
Simon GE; Unützer J
Psychiatr Serv; 1999 Oct; 50(10):1303-8. PubMed ID: 10506298
[TBL] [Abstract][Full Text] [Related]
20. Economic consequences of not recognizing bipolar disorder patients: a cross-sectional descriptive analysis.
Birnbaum HG; Shi L; Dial E; Oster EF; Greenberg PE; Mallett DA
J Clin Psychiatry; 2003 Oct; 64(10):1201-9. PubMed ID: 14658969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
